Rivas LR, López LE, Gastélum PC

Language: Spanish
References: 21
Page: 14-20
PDF size: 165.25 Kb.

ABSTRACT

Deaths from complications of obstetric procedures occur at a rate of 3.3 for each million pregnancies. Seldom, blood and/or its components are needed for the obstetric patient. It has been estimated that 1-2% of women will require a blood transfusion in relation to a delivery. It is therefore important to know the circumstances in which a major bleed may present, and to be prepared to prevent or treat these bleeding complications. In the present writing, we review the use of hemic components in obstetrics, as well as the major causes of hemorrhage and their consequences. We propose the approach to the treatment of bleeding complications, and the indications for the use of specific hematic fractions. There is a need to have a well implemented blood bank, and to work as a team in an interdisciplinary fashion, favoring the communication between the obstetrician, the hematologist and personnel from transfusion medicine, in order to have optimal results.

REFERENCES

1. Karalapillai D, Popham P. Recombinant factor VIIa in massive postpartum hemorrhage. Intern J Obstet Anesth 2007; 16: 29-34.

2. Baskett TF. Blundell J. The first transfusion of human blood. Resuscitation 2002; 52(3): 229-33.

3. Cohen WR. Hemorrhagic shock in obstetrics. J Perinat Med 2000; 271-73.4. Macphail S, Talks K. Massive post-partum haemorrhage and management of disseminated intravascular coagulation. Curr Obstet Gynecol 2004; 14: 123-31.

4. Gombotz H, Metzler H, List WF. Methods for reduction of perioperative bleeding. Br J Anaesth 1998; 81 (Suppl 1): 62-6.

5. Silverman JA, Barret J, Callum JL. The appropriateness of red blood cell transfusions in the peripartum patient. Obstet Gynecol 2004; 104: 1000-4.

6. Joseph KS, Rouleau J, Kramer KS et al. Investigation of an increase in postpartum haemorrhage in Canada. Br J Obstet Gynecol 2007; 114: 751-9.

7. Santoso JT, Brook AS, Grosshart K. Massive blood loss and transfusion in obstetrics and gynecology. Obstetr Gynecol Surv 2005; 60(12): 827-37.

8. Palo R, Ahonen J, Salo H et al. Transfusion of red blood cells: no impact on length of hospital stay in moderately anaemic parturients. Acta Anaesthesiol Scand 2007; 51: 565-9.

9. Broche, DE, Gay, C, Armand-Branger S et al. Severe anaemia in the immediate post-partum period. Clinical practice and value of intravenous iron. Eur J Obstet Gynecol Reproduc Biol 2005; 123: S-21-S27.

10. Klapholz H. Blood transfusion in contemporary obstetric practice. 1990; 75: 940-3.

11. Ries A, Kopelman JN. Routine blood bank request in obstetrics: a safe and effective policy. Prim Care Update Obstet Gynecol 1998; 5: 136-9.

12. Baskett, TF. Trends in blood transfusion in obstetrics. Obstet Gynecol 2006; 107(4): S62.

13. Baskett TF, O’Connell CM. Severe obstetric maternal morbidity: an 15-year population-based study. J Obstet Gynaecol 2005; 25(1): 7-9.

14. Mc Cullough J. Transfusion medicine. Second Edition. Ed. Elsevier. USA. Chap. 12. Transfusion Therapy in Specific Clinical Situations, 2005: 309-58.

15. Ekeroma A. Blood transfusion in obstetrics. Gynaecology 1997; 104(3): 278-84.G

16. Crosby E. Re-evaluating the transfusion trigger: how low is safe? Am J Therap 2002; 9: 411-6.

17. Carson JL, Hill S, Carless, P et al. Transfusion triggers: a systematic review of the literature. Trans Med Rev 2002; 16(3): 187-9.

18. Marshall JC. Transfusion trigger; when to transfuse? Critical Care 2004; 8 (Suppl 2): S31-S33.

19. Rodríguez-Moyado H. Indicaciones para transfusión de eritrocitos. Rev Med IMSS 2004; 42(2): 145-54.

20. Anderson JM. Prevention and management of postpartum hemorrhage. Am Fam Physician 2007; 75: 875-82.

21. Franchini M. The use of recombinant activated factor VII in life-threatening postpartum hemorrhage. Br J Obstet Gynecol 2007; 114(1): 8-15.